Home Cart 0 Sign in  

[ CAS No. 132336-37-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 132336-37-9
Chemical Structure| 132336-37-9
Structure of 132336-37-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 132336-37-9 ]

Related Doc. of [ 132336-37-9 ]

Alternatived Products of [ 132336-37-9 ]

Product Details of [ 132336-37-9 ]

CAS No. :132336-37-9 MDL No. :MFCD23135282
Formula : C15H18N3O7P Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 383.29 Pubchem ID :-
Synonyms :

Safety of [ 132336-37-9 ]

Signal Word: Class:
Precautionary Statements: UN#:
Hazard Statements: Packing Group:

Application In Synthesis of [ 132336-37-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 132336-37-9 ]

[ 132336-37-9 ] Synthesis Path-Downstream   1~1

  • 1
  • [ 132336-37-9 ]
  • [ 113852-37-2 ]
YieldReaction ConditionsOperation in experiment
80% With ammonium hydroxide at 20℃; for 3h; 5 Add 6a (0.21g, 0.55mmol) to the reaction flask and add 2mL concentrated ammonia water.The reaction was carried out for 3 h at room temperature. Concentrated under reduced pressure to give a white solid.Slowly add concentrated hydrochloric acid to pH=3.5, and react at room temperature for 5 hours.Concentration under reduced pressure gave a white solid.Yield 80%,Ee>99%,
With ammonium hydroxide for 4h; Ambient temperature; Yield given;
1 A procedure from the literature for synthesizing cidofovir (P.R. Brodfuehrer, et al., Tetrahedron Lett. 35, 1994, 3243-3246, herein incorporated by reference) was modified. The modified synthesis reaction is shown in Figure 3. The literature procedure of reacting tritylated R-glycidol and benzoyl protected cytosine produced low yields. Therefore, as shown in Figure 3, tritylated R-glycidol (compound 10), (5.0 mmol) was treated with unprotected cytosine (5.0 mmol) in the presence Of K2CO3 (5.0 mmol) in DMF (20 mL) for 5h at 105 0C to obtain regiospecific opening of the epoxide, giving compound 11, (S)-N1-[(2-hydroxy-3-triphenylmethoxy) propyl]cytosine). A benzoyl moiety was then introduced by reacting compound 11 (3.6 mmol) and benzoic anhydride (1.2 eq) in pyridine (15.5 mL) and DMF (8 mL) at 10°C for 3 h to obtain the desired product, compound 12, (
Same Skeleton Products
Historical Records